Filing metadata

Accession number
0001127602-24-004711
Form type
Form 4
Filer
Apellis Pharmaceuticals, Inc.
CIK
CIK 1492422
Filed
Feb 13, 2024
Reporting period
Feb 12, 2024
Description
Insider transaction

Explore SEC Filings Hub